Polyelectrolyte-protein synergism: pH-responsive polyelectrolyte/insulin complexes as versatile carriers for targeted protein and drug delivery.

Block polyelectrolyte Core/shell particles Electrostatic co-assembly Insulin Protein Small-angle scattering

Journal

Journal of colloid and interface science
ISSN: 1095-7103
Titre abrégé: J Colloid Interface Sci
Pays: United States
ID NLM: 0043125

Informations de publication

Date de publication:
23 Mar 2024
Historique:
received: 31 12 2023
revised: 10 03 2024
accepted: 23 03 2024
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 31 3 2024
Statut: aheadofprint

Résumé

The co-assembly of polyelectrolytes (PE) with proteins offers a promising approach for designing complex structures with customizable morphologies, charge distribution, and stability for targeted cargo delivery. However, the complexity of protein structure limits our ability to predict the properties of the formed nanoparticles, and our goal is to identify the key triggers of the morphological transition in protein/PE complexes and evaluate their ability to encapsulate multivalent ionic drugs. A positively charged PE can assemble with a protein at pH above isoelectric point due to the electrostatic attraction and disassemble at pH below isoelectric point due to the repulsion. The additional hydrophilic block of the polymer should stabilize the particles in solution and enable them to encapsulate a negatively charged drug in the presence of PE excess. We demonstrated that diblock copolymers, poly(ethylene oxide)-block-poly(N,N-dimethylaminoethyl methacrylate) and poly(ethylene oxide)-block-poly(N,N,N-trimethylammonioethyl methacrylate), consisting of a polycation block and a neutral hydrophilic block, reversibly co-assemble with insulin in pH range between 5 and 8. Using small-angle neutron and X-ray scattering (SANS, SAXS), we showed that insulin arrangement within formed particles is controlled by intermolecular electrostatic forces between protein molecules, and can be tuned by varying ionic strength. For the first time, we observed by fluorescence that formed protein/PE complexes with excess of positive charges exhibited potential for encapsulating and controlled release of negatively charged bivalent drugs, protoporphyrin-IX and zinc(II) protoporphyrin-IX, enabling the development of nanocarriers for combination therapies with adjustable charge, stability, internal structure, and size.

Identifiants

pubmed: 38555748
pii: S0021-9797(24)00658-1
doi: 10.1016/j.jcis.2024.03.156
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

801-813

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Anastasiia Murmiliuk (A)

Jülich Centre for Neutron Science (JCNS) at Heinz Maier-Leibnitz Zentrum (MLZ), Forschungszentrum Jülich GmbH, Lichtenbergstraße 1, 85747 Garching, Germany. Electronic address: anastasiia.murmiliuk@gmail.com.

Hiroki Iwase (H)

Neutron Science and Technology Center, Comprehensive Research Organization for Science and Society (CROSS), Tokai, Ibaraki 319-1106, Japan.

Jia-Jhen Kang (JJ)

Jülich Centre for Neutron Science (JCNS) at Heinz Maier-Leibnitz Zentrum (MLZ), Forschungszentrum Jülich GmbH, Lichtenbergstraße 1, 85747 Garching, Germany.

Shilpa Mohanakumar (S)

Physics of Complex Fluids, University of Twente, 7522 NB Enschede, The Netherlands.

Marie-Sousai Appavou (MS)

Jülich Centre for Neutron Science (JCNS) at Heinz Maier-Leibnitz Zentrum (MLZ), Forschungszentrum Jülich GmbH, Lichtenbergstraße 1, 85747 Garching, Germany.

Kathleen Wood (K)

Australian Centre for Neutron Scattering, Australian Nuclear Science and Technology Organization, New Illawarra Road, Lucas Heights, NSW 2234, Australia.

László Almásy (L)

Neutron Spectroscopy Department, HUN-REN Centre for Energy Research, Konkoly-Thege str. 29-33, 1121 Budapest, Hungary.

Adél Len (A)

Neutron Spectroscopy Department, HUN-REN Centre for Energy Research, Konkoly-Thege str. 29-33, 1121 Budapest, Hungary; University of Pécs, Faculty of Engineering and Information Technology, Boszorkány str 2., 7624 Pécs, Hungary.

Kuno Schwärzer (K)

Jülich Centre for Neutron Science (JCNS-1/IBI-8), Forschungszentrum Jülich, Wilhelm-Johnen-Straße, 52425 Jülich, Germany.

Jürgen Allgaier (J)

Jülich Centre for Neutron Science (JCNS-1/IBI-8), Forschungszentrum Jülich, Wilhelm-Johnen-Straße, 52425 Jülich, Germany.

Martin Dulle (M)

Jülich Centre for Neutron Science (JCNS-1/IBI-8), Forschungszentrum Jülich, Wilhelm-Johnen-Straße, 52425 Jülich, Germany.

Thomas Gensch (T)

Institute of Biological Information Processing, IBI-1 (Molecular and Cellular Physiology), Forschungszentrum Jülich, 52425 Jülich, Germany.

Beate Förster (B)

Ernst Ruska-Centre for Microscopy and Spectroscopy with Electrons, Physics of Nanoscale Systems (ER-C-1), Forschungszentrum Jülich, Wilhelm-Johnen-Straße, 52425 Jülich, Germany.

Kanae Ito (K)

Industrial Application Division, Spring-8, Japan Synchrotron Radiation Research Institute (JASRI), 1-1-1 Kouto, Sayo, Hyogo 679-5198, Japan.

Hiroshi Nakagawa (H)

Materials Sciences Research Center, Japan Atomic Energy Agency, Tokai, Ibaraki, Japan.

Simone Wiegand (S)

IBI-4-Biomacromolecular Systems and Processes, Forschungszentrum Jülich GmbH, D-52428 Jülich, Germany; Chemistry Department - Physical Chemistry, University Cologne, D-50939 Cologne, Germany.

Stephan Förster (S)

Jülich Centre for Neutron Science (JCNS-1/IBI-8), Forschungszentrum Jülich, Wilhelm-Johnen-Straße, 52425 Jülich, Germany.

Aurel Radulescu (A)

Jülich Centre for Neutron Science (JCNS) at Heinz Maier-Leibnitz Zentrum (MLZ), Forschungszentrum Jülich GmbH, Lichtenbergstraße 1, 85747 Garching, Germany.

Classifications MeSH